Cervical spondylotic myelopathy: Changes of fractional anisotropy in the spinal cord and magnetic resonance spectroscopy of the primary motor cortex in relation to clinical symptoms and their duration.
Aged
Anisotropy
Aspartic Acid
/ analogs & derivatives
Biomarkers
/ metabolism
Cervical Vertebrae
/ diagnostic imaging
Creatine
/ metabolism
Female
Humans
Inositol
/ metabolism
Magnetic Resonance Spectroscopy
/ methods
Male
Middle Aged
Motor Cortex
/ diagnostic imaging
Spinal Cord Diseases
/ metabolism
Spondylosis
/ metabolism
Time Factors
Magnetic resonance imaging
Magnetic resonance spectroscopy
Spinal cord diseases
Spondylosis
Journal
European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
16
11
2018
revised:
22
03
2019
accepted:
15
04
2019
entrez:
3
6
2019
pubmed:
4
6
2019
medline:
5
9
2019
Statut:
ppublish
Résumé
To determine the changes in fractional anisotropy (FA) at the proximal spinal cord and in magnetic resonance spectroscopy (MRS) of the precentral gyrus in patients with cervical spondylotic myelopathy (CSM) with respect to clinical symptoms and their duration. 20 patients with CSM (7 female; mean age 64.6 ± 10.5 years) and 18 age/sex matched healthy controls (9 female; mean age 63.5 ± 6.6 years) were prospectively included. Clinical data (modified Japanese Orthopaedic Association Score (mJOA) and Neck Disability Index (NDI)) and 3T MR measurements including DTI at the spinal cord (level C2/3) with FA and MRS of the left and right precentral gyrus were taken. Clinical correlations and regression analyses were performed. Mean clinical scores of patients were significantly different to controls (mJOA; CSM: 10.2 ± 2.9; controls: 18.0 ± 0.0, p < 0.001; NDI; CSM: 41.4±23.5; controls: 4.4±6.6, p<0.001); FA was significantly lower in patients (CSM: 0.645 ± 0.067; controls: 0.699 ± 0.037, p = 0.005). MRS showed significantly lower metabolite concentrations between both groups: creatine (Cr) (CSM: 46.46±7.64; controls: 51.36±5.76, p = 0.03) and N-acetylaspartate (NAA) (CSM: 93.94±19.22; controls: 107.24±20.20, p = 0.05). Duration of symptoms ≤6 months was associated with increased myo-inositol (Ins) (61.58±17.76; 44.44±10.79; p = 0.02) and Ins/Cr ratio (1.36±0.47; 0.96±0.18; p = 0.014) compared to symptoms >6 months. Metabolic profiles of the precentral gyrus and FA in the uppermost spinal cord differ significantly between patients and healthy controls. Ins, thought to be a marker of endogenous neuroinflammatory response, is high in the early course of CSM and normalizes over time.
Identifiants
pubmed: 31153574
pii: S0720-048X(19)30143-3
doi: 10.1016/j.ejrad.2019.04.009
pii:
doi:
Substances chimiques
Biomarkers
0
Aspartic Acid
30KYC7MIAI
Inositol
4L6452S749
N-acetylaspartate
997-55-7
Creatine
MU72812GK0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
55-60Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.